Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

Preclinical evidence for implementing a prime-boost vaccine strategy for tuberculosis.

Brennan MJ, Clagett B, Fitzgerald H, Chen V, Williams A, Izzo AA, Barker LF.

Vaccine. 2012 Apr 16;30(18):2811-23. doi: 10.1016/j.vaccine.2012.02.036. Epub 2012 Mar 3. Review.

2.

Clinical Testing of Tuberculosis Vaccine Candidates.

Hatherill M, Tait D, McShane H.

Microbiol Spectr. 2016 Oct;4(5). doi: 10.1128/microbiolspec.TBTB2-0015-2016. Review.

PMID:
28087924
3.

Use of recombinant virus-vectored tuberculosis vaccines for respiratory mucosal immunization.

Xing Z, Lichty BD.

Tuberculosis (Edinb). 2006 May-Jul;86(3-4):211-7. Epub 2006 Feb 28. Review.

PMID:
16504584
4.

Recent findings in immunology give tuberculosis vaccines a new boost.

Kaufmann SH.

Trends Immunol. 2005 Dec;26(12):660-7. Epub 2005 Oct 21. Review.

PMID:
16246622
5.

Fact and fiction in tuberculosis vaccine research: 10 years later.

Kaufmann SH.

Lancet Infect Dis. 2011 Aug;11(8):633-40. doi: 10.1016/S1473-3099(11)70146-3. Review.

PMID:
21798463
6.

[Novel vaccines against M. tuberculosis].

Okada M.

Kekkaku. 2006 Dec;81(12):745-51. Review. Japanese.

PMID:
17240920
7.

Heterologous boost vaccines for bacillus Calmette-Guérin prime immunization against tuberculosis.

Xing Z, Charters TJ.

Expert Rev Vaccines. 2007 Aug;6(4):539-46. Review. Erratum in: Expert Rev Vaccines. 2008 Mar;7(2):274. Carters, Thomas James [corrected to Charters, Thomas James].

PMID:
17669008
8.

Tuberculosis vaccine types and timings.

Orme IM.

Clin Vaccine Immunol. 2015 Mar;22(3):249-57. doi: 10.1128/CVI.00718-14. Epub 2014 Dec 24. Review.

9.

New tuberculosis vaccines.

Martín Montañés C, Gicquel B.

Enferm Infecc Microbiol Clin. 2011 Mar;29 Suppl 1:57-62. doi: 10.1016/S0213-005X(11)70019-2. Review.

PMID:
21420568
10.

Vaccines for tuberculosis: novel concepts and recent progress.

Doherty TM, Andersen P.

Clin Microbiol Rev. 2005 Oct;18(4):687-702. Review.

11.

MVA-85A, a novel candidate booster vaccine for the prevention of tuberculosis in children and adults.

Nicol MP, Grobler LA.

Curr Opin Mol Ther. 2010 Feb;12(1):124-34. Review.

PMID:
20140824
12.

Recombinant BCG vaccine candidates.

Hernàndez-Pando R, Castañòn M, Espitia C, Lopez-Vidal Y.

Curr Mol Med. 2007 Jun;7(4):365-72. Review.

PMID:
17584076
13.

Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials.

McShane H, Pathan AA, Sander CR, Goonetilleke NP, Fletcher HA, Hill AV.

Tuberculosis (Edinb). 2005 Jan-Mar;85(1-2):47-52. Epub 2005 Jan 21. Review.

PMID:
15687027
14.

Advances in tuberculosis vaccine strategies.

Skeiky YA, Sadoff JC.

Nat Rev Microbiol. 2006 Jun;4(6):469-76. Review.

PMID:
16710326
15.

The current state of tuberculosis vaccines.

Hokey DA, Ginsberg A.

Hum Vaccin Immunother. 2013 Oct;9(10):2142-6. doi: 10.4161/hv.25427. Epub 2013 Jun 21. Review.

16.

Immunization strategies against pulmonary tuberculosis: considerations of T cell geography.

Horvath CN, Xing Z.

Adv Exp Med Biol. 2013;783:267-78. doi: 10.1007/978-1-4614-6111-1_14. Review.

PMID:
23468114
17.

The quest for a new vaccine against tuberculosis.

Delogu G, Fadda G.

J Infect Dev Ctries. 2009 Feb 28;3(1):5-15. Review.

18.

Vaccine development for tuberculosis: current progress.

Orme IM.

Drugs. 2013 Jul;73(10):1015-24. doi: 10.1007/s40265-013-0081-8. Review.

19.

Tuberculosis vaccines: progress and challenges.

Checkley AM, McShane H.

Trends Pharmacol Sci. 2011 Oct;32(10):601-6. doi: 10.1016/j.tips.2011.06.003. Epub 2011 Jul 29. Review.

PMID:
21803435
20.

The use of mutant mycobacteria as new vaccines to prevent tuberculosis.

Hernàndez Pando R, Aguilar LD, Infante E, Cataldi A, Bigi F, Martin C, Gicquel B.

Tuberculosis (Edinb). 2006 May-Jul;86(3-4):203-10. Epub 2006 Mar 20. Review.

PMID:
16542875

Supplemental Content

Support Center